STOCKHOLM, April 10, 2018 /PRNewswire/ -- Moberg Pharma´s
Annual Report for 2017 has been published and is available on
www.mobergpharma.com
About this information
Moberg Pharma AB is obliged to make this information public
pursuant to the EU Market Abuse Regulation (MAR). The information
was submitted for publication, through the agency of the contact
person set out above, at 08:30 a.m.
(CET) on April 10th, 2018.
For more information, please contact:
Peter Wolpert
CEO
phone: +1-908-432-22-03 (US)
+46-70-735-71-35
e-mail: peter.wolpert@mobergpharma.se
Anna Ljung,
CFO
phone: +46-70-766-60-30
e-mail: anna.ljung@mobergpharma.se
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/moberg-pharma/r/moberg-pharma-annual-report-2017,c2490385
The following files are available for download:
|
http://mb.cision.com/Main/1662/2490385/818335.pdf
|
Moberg Pharma Annual
Report 2017
|
View original
content:http://www.prnewswire.com/news-releases/moberg-pharma-annual-report-2017-300627023.html
SOURCE Moberg Pharma